Cardio Diagnostics Inc.

What does our testing process look like? Scroll through our thread for a look into our process. From sample collection to consultation, our tests are designed to simplify heart attack risk assessment and the diagnosis of coronary heart disease (CHD) so that you can take more proactive control of your heart health. Learn more here: cdio.ai/patients/request-tes… #LaboratoryWorkflow #ClinicalLaboratory #MachineLearning #PrecisionMedicine

Employers can expect health benefit costs to go up 8.2% per employee in 2027. This marks the fifth consecutive year of escalating costs, challenging employers to develop strategies to minimize shifting the cost burden to employees. Developing strategies that focus on high-cost claims continues to be the top priority for employers surveyed by @MarshGlobal, with 89% designating it as very important or important. At Cardio Diagnostics, we help employers tackle high-cost claims that arise from cardiovascular disease, a leading driver of claims and medical costs (@CDCgov). Our precision medicine solutions help employees improve their cardiovascular health and prevent life-threatening cardiac events, while helping employers avoid high-cost claims. Learn how we work with employers: cdio.ai/employers #EmployeeBenefits #HealthBenefits #BenefitsStrategy

Roughly 1 in 4 women with acute coronary syndrome (ACS) don't present with chest pain, according to a study by van Oosterhout et al. published in @JAHA_AHA in 2020. ACS can manifest as unstable angina or heart attacks caused by a partial or complete coronary artery blockage. While chest pain was the most common symptom experienced by women with ACS, they were more likely to present with less suspecting symptoms such as pain between the shoulder blades, nausea or vomiting, and shortness of breath. These symptoms can be easily overlooked, and waiting for them isn’t a strategy. That’s why assessing risk before symptoms ever appear is key. For women with no signs of coronary heart disease, Epi+Gen CHD™ helps you and your provider have insight into your three-year risk of a coronary heart disease event, including a heart attack. It analyzes genetic and epigenetic biomarkers using AI, delivering a risk assessment that’s demonstrated to be more sensitive than conventional risk calculators. Learn about how epigenetic-genetic testing can improve insight into heart health for women: cdio.ai/articles/heart-disea… #CardiovascularDisease #WomensHealth #HeartAttack #HealthEquity

What if you could learn not just whether a signal associated with coronary heart disease (CHD) is present, but what’s driving it? PrecisionCHD™ is a simple clinical blood test that helps uncover the specific molecular drivers of CHD for each patient, without requiring radiation or fasting. When you test with PrecisionCHD, your ordering provider receives a report that explains the “why” behind your results, such as lifestyle and environmental drivers that may be contributing to disease. Get more personalized and better-informed care to manage your disease with PrecisionCHD: cdio.ai/solutions/precision-…

Did you know? AI applications in medicine are less novel than you might think. Theoretical applications began as early as the 1950s, and use cases have since grown more complex, expanding into real-world areas such as surgery, disease diagnosis, and genomic research. One of the earliest and most widely recognized medical AI expert systems was MYCIN, developed at Stanford University in the mid-1970s to diagnose and treat bacterial infections. Today, AI-based solutions have surged across healthcare, bringing significant opportunity but also complexity. It's critical that healthcare organizations understand the purpose behind a given AI use case before adopting it. Cardio Diagnostics pioneered the first AI-driven multi-omics engine for precision cardiovascular medicine. Our blood tests combine epigenetics, genetics, and AI to reshape how we assess an individual’s likelihood of having a heart attack or developing coronary heart disease. Learn more about our advanced technology here: cdio.ai/company/technology #AIHistory #ScienceHistory #HealthTech

We’re looking forward to exhibiting at the @IFEBP's Annual Employee Benefits Conference from October 25-28 in New Orleans. We’re excited to connect with benefit professionals and industry leaders to discuss how our solutions can help strengthen benefit strategies and enhance health outcomes for organizations. Our evidence-based blood tests for the prevention and early detection of coronary heart disease provide employees with a deeper understanding of their heart health. We seamlessly integrate into an organization’s workflow and manage test program logistics end-to-end, from pre-testing education to post-testing support. The results support a healthier, informed workforce equipped with insights to actively take charge of their health, while help organizations reduce total healthcare spend. Interested in learning more about how our tests can strengthen employee heart health within your organization and help your organization reduce spend? Connect with us at Booth 220 at the conference. #IFAnnual #EmployeeBenefits

October is Health Literacy Month, a time to bring focus to the importance of delivering health information in a way that is clear, accessible, and actionable. Understanding your cardiovascular health is often daunting and time-consuming. According to survey data by @AMNHealthcare, the average wait time for an appointment with a cardiologist was 32.7 days. Additionally, diagnostic tools such as EKGs, stress testing, and/or coronary angiograms often require specialist expertise to interpret. Epigenetic-genetic testing through PrecisionCHD™ complements traditional strategies for more comprehensive results. Through a simple blood test, PrecisionCHD™ evaluates a patient’s unique biomarkers associated with coronary heart disease (CHD), capturing signals that other diagnostics may miss, such as non-obstructive CHD. This test is available to patients in a traditional clinical setting or via telemedicine, eliminating wait times and the need for multiple follow-up appointments. Ready to get more informed about your heart health? Learn about how PrecisionCHD can help detect a signal for CHD: cdio.ai/solutions/precision-… #HealthLiteracyMonth #DiagnosticTesting #Epigenetics

Can loneliness increase risk for a heart attack? According to research published in 2022 in the Journal of American Heart Association by Cené et al., social isolation and chronic loneliness can increase the risk of a heart attack or stroke by 30%. Social isolation and loneliness can trigger stress hormones and inflammation comparable to the impact of smoking. Among patients with existing coronary heart disease, smaller social networks are associated with recurrent cardiovascular events and mortality. These findings are particularly impactful for older adults who are more predisposed to developing cardiovascular risk factors (CDC). The key takeaway? Don’t overlook your social wellbeing when it comes to maintaining your overall heart health. #SocialHealth #SocialConnection #HeartDisease #HeartHealth